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The essential amino acid leucine serves as a signal that activates protein synthesis. A new study by
She et al. (2007) in this issue of Cell Metabolism shows that raising circulating leucine by blocking
leucine breakdown drives a futile cycle of protein synthesis and degradation that contributes to
higher-energy expenditure, resistance to dietary obesity, and improved insulin sensitivity.In the continuing search for the magic
combination of nutrients that will facil-
itate weight loss or prevent obesity,
high-protein diets have broad popular-
ity. However, there is scant evidence
for a long-term effect of dietary protein
on body composition (Astrup, 2005;
Lejeune et al., 2006). This is because
elaborate, but as yet poorly under-
stood mechanisms, regulate the in-
take and utilization of dietary protein,
and their component amino
acids, for energy and protein
synthesis. The branched-
chain amino acids (BCAA)
are essential in the diet,
meaning that they cannot
be made by mammals.
BCAA differ from other es-
sential amino acids in that
they are primarily metabo-
lized in peripheral tissues,
mainly muscle, but not by
the liver. Thus, circulating
BCAA rise after a protein
meal, and this serves as
a signal to activate protein
synthesis via activation of
mTOR kinase and its down-
stream targets (Marshall,
2006). Leucine may also
act in the hypothalamus,
via mTOR, to suppress
food intake (Cota et al.,
2006). To assess the long-
term consequences of ele-
vated leucine signaling,
She et al. (2007) engineered
a mouse lacking mitochon-
drial branched chain amino-
transferase (BCATm), the
first enzyme in the catabo-
lism of BCAA.
BCAA metabolism begins with
transamination by BCATm, a mito-
chondrial enzyme present in most
tissues, to produce the a-ketoacids.
BCATm/ mice ate less food when
provided with regular chow that in-
cluded relatively high levels of BCAA.
Therefore, She et al. took advantage
of the ability of rodents to select diets
based on amino acid composition.
When provided with two diets, one
normal and one devoid of BCAA, the
BCATm/ mice selected more of the
BCAA-free diet but ate similar amounts
of protein and total calories. Thus, they
were consuming 20%–30%more food
relative to their smaller body size. The
mice appeared healthy and despite
their higher caloric intake maintained
a lower body weight and were half as
fat as controls. When challenged with
a high-fat diet that caused obesity in
controls, the BCAT null
mice remained lean. Mea-
surements of oxygen con-
sumption revealed an
increased metabolic rate
(20%–30% over 24 hr)
in the BCATm/ mice, so
they could eat more without
gaining further weight, the
dieter’s dream.
As expected, the block-
ade in BCAA metabolism in
the BCATm null mice mark-
edly increased circulating
BCAA including leucine by
>10-fold and increased pro-
tein synthesis by 40% in
most tissues. Body and or-
gan weights, however,
were not increased, sug-
gesting that protein break-
down was also increased.
Increased urinary 3-methyl-
histidine excretion (an indi-
cator of skeletal muscle pro-
teolysis) confirmed higher
rates of protein degrada-
tion. The importance of the
increased protein turnover
for the elevated energy ex-
penditure was supported
by the demonstration that
Figure 1. Deletion of BCATm Initiates an Energy-Wasting
Futile Cycle
Deletion of BCATm prevents the first step in BCAA catabolism, in-
creasing circulating leucine (and other BCAA), which results in a futile
and energy-consuming cycle of increased protein synthesis and
breakdown. While in wild-type mice, leucine breakdown produces
a-ketoisocaproate (KIC) that is thought to simultaneously slow protein
breakdown, this inhibition does not occur in the BCATm null mice. The
mice show increased food intake for their body size yet remain lean
due to increased energy expenditure. They are also insulin sensitive
and resistant to becoming obese on high-fat diet.Cell Metabolism 6, September 2007 ª2007 Elsevier Inc. 155
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synthesis with rapamycin partially nor-
malized energy expenditure. Thus, this
novel mouse model provides proof of
principle that an increase in energy uti-
lization for a ‘‘futile’’ cycle can increase
whole-body energy expenditure and
regulate body fat over the long term
(Figure 1).
In contrast to the 10-fold increased
circulating leucine in BCATm defi-
ciency, increasing dietary leucine can
only increase levels by less than
2-fold (Zhang et al., 2007). Furthermore,
diet-induced increases in leucine si-
multaneously stimulate protein syn-
thesis and slow protein degradation,
resulting in the net accumulation of tis-
sue protein during growth or recovery
from stress. This occurs because the
product of the leucine metabolism,
a-ketoisocaproic acid (KIC), inhibits
proteolysis (Mitch et al., 1981). The
block in leucine catabolism in the
BCATm/ mice prevents the genera-
tion of KIC that would normally inhibit
protein breakdown, resulting in a futile
cycle. Although circulating KIC con-
centrations were unchanged in the
BCATm/, it seems likely that levels
of KIC within tissues such as skeletal
muscle would be decreased. Further
research should address this question.
Unfortunately for dieters, it appears
unlikely that the tactic used by the
BCATm/ mice to avoid weight
gain, i.e., a big increase in protein turn-
over, can be achieved by merely in-
gesting high-protein diets or leucine
supplements.
As with all genetically engineered
animal models, the development of
BCATm/ mice raises many more
questions than can be answered in156 Cell Metabolism 6, September 2007an initial report. For example, what
happens to the excess BCAA, are
they metabolized through an alterna-
tive pathway, and if so where, or are
they excreted? Also, do they have ef-
fects that have not yet been detected?
For example, BCAA are transported by
the same transporter as tryptophan,
so what happens to tryptophan (a
precursor of serotonin) availability
within tissues such as the brain and
what are the consequences? The
BCATm/ mice were also more glu-
cose tolerant and insulin sensitive,
even when placed on a high-fat diet.
It is unclear whether this results simply
from their leanness or whether addi-
tional mechanisms are involved. Also,
the increased insulin sensitivity may
contribute to higher protein synthesis,
which remains to be tested.
Elaborate mechanisms normally
match energy intake to expenditure
so that body weight is regulated with
narrow limits (Schwartz and Porte,
2005). At first glance, the hyperphagia
of the BCATm/ mice could be
viewed as evidence that high levels of
circulating leucine in the periphery
may not lead to elevated hypothalamic
leucine that is known to inhibit food in-
take (Cota et al., 2006). However, it
seems likely that this pathway was
not operative, as, if it had been, the an-
imalsmay have become evenmore hy-
perphagic. Theeffects of hypothalamic
mTOR blockade in the BCATm/
mice would therefore be revealing.
The mechanism of metabolic ineffi-
ciency in the BCATm null mouse
stands in contrast to several other
mouse models of resistance to dietary
obesity (Evans et al., 2004). More com-
monly, mice increase energy expendi-ª2007 Elsevier Inc.ture though induction of uncoupling
proteins (UCPs) in brown adipose tis-
sue mitochondria, increasing a proton
leak that ‘‘wastes’’ energy as heat.
She et al. could not detect any increase
in UCP proteins in brown adipose tis-
sue (BAT) or muscle of BCAT null ani-
mals. Since adult humans lack brown
adipose tissue, it is possible that rev-
ving up protein turnover by manipulat-
ingBCATmactivity throughpharmaco-
logical means is worth exploring as
a treatment for obesity in humans, as
She et al. speculate. Additional studies
of mechanisms through which leucine
signals protein turnover and food intake
may offer an additional lifeline for the
majority of us who are trying to resist
weight gain in our sedentary society.
REFERENCES
Astrup, A. (2005). Am. J. Clin. Nutr. 82, 1–2.
Cota, D., Proulx, K., Smith, K.A., Kozma, S.C.,
Thomas, G., Woods, S.C., and Seeley, R.J.
(2006). Science 312, 927–930.
Evans, R.M., Barish, G.D., and Wang, Y.X.
(2004). Nat. Med. 10, 355–361.
Lejeune, M.P., Westerterp, K.R., Adam, T.C.,
Luscombe-Marsh, N.D., and Westerterp-Plan-
tenga,M.S. (2006). Am. J. Clin. Nutr. 83, 89–94.
Marshall, S. (2006). Sci. STKE 346, re7.
Mitch, W.E., Walser, M., and Sapir, D.G.
(1981). J. Clin. Invest. 67, 553–562.
Schwartz, M.W., and Porte, D., Jr. (2005). Sci-
ence 307, 375–379.
She, P., Reid, T.M., Braonson, S.K., Vary, T.C.,
Hajnal, A., Lyngch, C.J., and Hutson,
S.M. (2007). Cell Metab. 6, this issue,
181–194.
Zhang, Y., Guo, K., LeBlanc, R.E., Loh, D.,
Schwartz, G.J., and Yu, Y.H. (2007). Diabetes
56, 1647–1654.
